Last reviewed · How we verify
Folinic Acid
Folinic Acid is a Small molecule drug developed by UNICANCER. It is currently FDA-approved. Also known as: leucovorin, leucovorin calcium, Calcium folinate Leucovorin, Leucovorin.
At a glance
| Generic name | Folinic Acid |
|---|---|
| Also known as | leucovorin, leucovorin calcium, Calcium folinate Leucovorin, Leucovorin, LV |
| Sponsor | UNICANCER |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia (PHASE2)
- A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia (PHASE3)
- A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer (PHASE2)
- Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44) (PHASE2)
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial (PHASE2)
- Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations (PHASE3)
- Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT Study (PHASE3)
- Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial) (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Folinic Acid CI brief — competitive landscape report
- Folinic Acid updates RSS · CI watch RSS
- UNICANCER portfolio CI
Frequently asked questions about Folinic Acid
What is Folinic Acid?
Folinic Acid is a Small molecule drug developed by UNICANCER.
Who makes Folinic Acid?
Folinic Acid is developed and marketed by UNICANCER (see full UNICANCER pipeline at /company/unicancer).
Is Folinic Acid also known as anything else?
Folinic Acid is also known as leucovorin, leucovorin calcium, Calcium folinate Leucovorin, Leucovorin, LV.
What development phase is Folinic Acid in?
Folinic Acid is FDA-approved (marketed).
Related
- Manufacturer: UNICANCER — full pipeline
- Also known as: leucovorin, leucovorin calcium, Calcium folinate Leucovorin, Leucovorin, LV
- Compare: Folinic Acid vs similar drugs
- Pricing: Folinic Acid cost, discount & access